Creutzfeldt-Jakob disease classification

Revision as of 19:45, 14 February 2014 by Twinkle Singh (talk | contribs)
Jump to navigation Jump to search

Creutzfeldt-Jakob disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Creutzfeldt-Jakob disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Creutzfeldt-Jakob disease classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Creutzfeldt-Jakob disease classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Creutzfeldt-Jakob disease classification

CDC on Creutzfeldt-Jakob disease classification

Creutzfeldt-Jakob disease classification in the news

Blogs on Creutzfeldt-Jakob disease classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Creutzfeldt-Jakob disease classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

The prion that is believed to cause Creutzfeldt-Jakob exhibits at least two stable conformations. One, the native state, is water-soluble and present in healthy cells. As of 2006, its biological function is unknown. The other conformational state is very poorly water-soluble and readily forms protein aggregates.

There are two types of CJD, classic and variant form. Classic CJD characteristics, as compared to variant CJD, are presented in the table below. The classic types of CJD are:

Sporadic CJD Most prevalent, idiopathic, average age of onset is 65 years
Familial CJD Results when a person inherited the abnormal prion (rare)

Parchi et al classified sporadic CJD (sCJD) based on molecular and phenotypic features.[1]

Previous classification sCJD variants according to Parchi et al Clinical features Neuropathological features
Myoclonic,
Heidenhan variants
MM1 or MV1 Rapidly progressive dementia
Myoclonus
Altered vision
Unilateral signs in beginning
Typical EEG findings
Occipital cortex involvement
Confluent vacuoles
Perivacuolar PrP staining
Ataxic variant VV2 Ataxia in early stage
Dementia in later stages
Typical EEG findings not present
Brainstem nuclei and
subcortical areas are affected
Perinuclear PrP staining
Plaque like focal Prp deposits
Kuru-plaques variant MV2 Ataxia
Dementia
Typical EEG findings not present
Longer duration (>2 yrs) compared to other variants
Amyloid-kuru plaques in cerebellum
Plaque like focal PrP deposits
Thalamic variant


Transmissible spongiform encephalopathy diseases are caused by prions. The diseases are thus sometimes called prion diseases. Other prion diseases include:

  • Clinical and Pathologic Characteristics:[2]
Characteristic Classic CJD Variant CJD
Median age at death 68 years 28 years
Median duration of illness 4-5 months 13-14 months
Clinical signs and symptoms Dementia; early neurologic signs Prominent psychiatric/behavioral symptoms; painful dysesthesias; delayed neurologic signs
Periodic sharp waves on electroencephalogram Often present Often absent
Signal hyperintensity in the caudate nucleus and putamen on diffusion-weighted and FLAIR MRI Often present Often absent
Pulvinar sign on MRI Not reported Present in >75% of cases
Immunohistochemical analysis of brain tissue Variable accumulation. Marked accumulation of protease-resistant prion protein
Presence of agent in lymphoid tissue Not readily detected Readily detected
Increased glycoform ratio on immunoblot analysis of protease-resistant prion protein Not reported Marked accumulation of protease-resistant prion protein
Presence of amyloid plaques in brain tissue May be present May be present

References

  1. Parchi, P.; Giese, A.; Capellari, S.; Brown, P.; Schulz-Schaeffer, W.; Windl, O.; Zerr, I.; Budka, H.; Kopp, N. (1999). "Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects". Ann Neurol. 46 (2): 224–33. PMID 10443888. Unknown parameter |month= ignored (help)
  2. Belay ED, Schonberger LB (2002). "Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy". Clin. Lab. Med. 22 (4): 849–62, v–vi. PMID 12489284.


Template:WikiDoc Sources